<DOC>
	<DOCNO>NCT01884272</DOCNO>
	<brief_summary>This drug-drug interaction study healthy volunteer evaluate potential pharmacokinetic ( PK ) effect non-steroidal anti-inflammatory drug lesinurad leinurad non-steroidal anti-inflammatory drug .</brief_summary>
	<brief_title>NSAID Drug Interaction Study</brief_title>
	<detailed_description>Naproxen indomethacin non-steroidal anti-inflammatory drug ( NSAIDs ) use prophylactically prevention , treatment , acute gout flare . RDEA594-126 open-label study design ass potential effect multiple dose naproxen indomethacin single-dose PK lesinurad , assess potential effect multiple dose lesinurad multiple-dose PK naproxen indomethacin .</detailed_description>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Lesinurad</mesh_term>
	<criteria>Subject body weight ≥ 50 kg ( 110 lb ) body mass index ( BMI ) ≥ 18 ≤ 30 kg/m2 . Subject free clinically significant disease require physician 's care and/or would interfere study evaluation procedure . Subject clinically relevant abnormality vital sign , ECG , physical examination safety laboratory value . Subject clinically significant pulmonary , cardiovascular , gastrointestinal , neurologic , hepatic , renal , urological , psychiatric disorder . Subject history suspicion kidney stone . Subject history asthma . Subject undergone major surgery within 3 month prior Day 1 . Subject donate blood experienced significant blood loss ( &gt; 450 mL ) within 12 week prior Day 1 give plasma donation within 4 week prior Screening visit . Subject inadequate venous access unsuitable vein repeat venipuncture .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>